chrX-71129785-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005120.3(MED12):​c.3797G>A​(p.Arg1266His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,208,906 control chromosomes in the GnomAD database, including 1 homozygotes. There are 66 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1266C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.00013 ( 1 hom. 63 hem. )

Consequence

MED12
NM_005120.3 missense

Scores

1
7
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: 7.50

Publications

5 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034648836).
BP6
Variant X-71129785-G-A is Benign according to our data. Variant chrX-71129785-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 129591.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000446 (5/112113) while in subpopulation SAS AF = 0.00111 (3/2692). AF 95% confidence interval is 0.000304. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.3797G>A p.Arg1266His missense_variant Exon 27 of 45 ENST00000374080.8 NP_005111.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.3797G>A p.Arg1266His missense_variant Exon 27 of 45 1 NM_005120.3 ENSP00000363193.3

Frequencies

GnomAD3 genomes
AF:
0.0000535
AC:
6
AN:
112060
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00111
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00417
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000164
AC:
29
AN:
176896
AF XY:
0.000284
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000253
Gnomad OTH exome
AF:
0.000230
GnomAD4 exome
AF:
0.000130
AC:
143
AN:
1096793
Hom.:
1
Cov.:
32
AF XY:
0.000174
AC XY:
63
AN XY:
362319
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26365
American (AMR)
AF:
0.00
AC:
0
AN:
35110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19355
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30167
South Asian (SAS)
AF:
0.00130
AC:
70
AN:
53850
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40379
Middle Eastern (MID)
AF:
0.00266
AC:
11
AN:
4133
European-Non Finnish (NFE)
AF:
0.0000630
AC:
53
AN:
841415
Other (OTH)
AF:
0.000196
AC:
9
AN:
46019
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000446
AC:
5
AN:
112113
Hom.:
0
Cov.:
23
AF XY:
0.0000875
AC XY:
3
AN XY:
34305
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30862
American (AMR)
AF:
0.00
AC:
0
AN:
10664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3551
South Asian (SAS)
AF:
0.00111
AC:
3
AN:
2692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6145
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53112
Other (OTH)
AF:
0.00
AC:
0
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000395
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.000231
AC:
28

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MED12: PP2, BS1 -

Mar 27, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 13, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25852444, 28454995) -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

FG syndrome Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MED12-related disorder Benign:1
Mar 19, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.15
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.055
T;.;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.035
T;T;T
MetaSVM
Uncertain
0.34
D
MutationAssessor
Benign
1.5
.;L;L
PhyloP100
7.5
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.6
.;N;N
REVEL
Uncertain
0.32
Sift
Benign
0.036
.;D;D
Sift4G
Uncertain
0.049
D;T;T
Polyphen
0.99
D;D;D
Vest4
0.18
MutPred
0.27
.;Loss of MoRF binding (P = 0.0202);Loss of MoRF binding (P = 0.0202);
MVP
0.89
MPC
1.7
ClinPred
0.14
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.48
gMVP
0.37
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780391; hg19: chrX-70349635; COSMIC: COSV61355387; COSMIC: COSV61355387; API